Kuala Lampur:Alpha IVF Group Bhd has announced its intention to move its listing from the ACE Market to the Main Market, with the transition expected to be completed by the fourth quarter of 2026.

According to BERNAMA News Agency, the fertility care specialist cited its growth, profitability, and financial stability as the reasons behind the proposed transfer. Alpha IVF has met the profit track record requirements for a transfer to Bursa Malaysia Securities Bhd via the accelerated transfer process.

The group's daily market capitalization during the six months from March 27, 2026, to September 28, 2026, has exceeded RM1 billion. It ranged from RM1.14 billion to RM1.35 billion, demonstrating the company's operational scale and market confidence.

The board of Alpha IVF believes that the proposed transfer will bolster the company's credibility, prestige, and reputation. It aims to achieve greater recognition and acceptance among investors, including institutional ones, thereby enhancing the marketability and attractiveness of Alpha IVF shares.

The transfer is anticipated to boost confidence among business partners, employees, and shareholders, aligning with the company's profile as a Main Market-listed entity. However, the transfer requires approvals from the Securities Commission Malaysia and Bursa Securities.

Alpha IVF was initially listed on the ACE Market on March 22, 2024. As of today, its share price increased by half-a-sen to 27 sen during the lunch break, up from 26.5 sen at Friday's close, with 2.62 million shares traded.